Obesity, macrophage migration inhibitory factor, and weight loss

被引:52
作者
Church, TS
Willis, MS
Priest, EL
LaMonte, MJ
Earnest, CP
Wilkinson, WJ
Wilson, DA
Giroir, BP
机构
[1] Ctr Integrated Hlth Res, Cooper Inst, Dallas, TX 75230 USA
[2] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA
关键词
cytokines; MIF; HOMA; intervention;
D O I
10.1038/sj.ijo.0802942
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Elevated macrophage migration inhibitory factor ( MIF) has been implicated as a causal mechanism in a number of disease conditions including cardiovascular disease ( CVD), diabetes, and cancer. Excess body fat is associated with an increased risk of numerous health conditions including CVD, diabetes, and cancer. To our knowledge, the association between MIF and obesity status and the effect of weight loss on serum MIF concentrations have not been reported. In this study, we examined the effects of participation in a behavior- based weight loss program on MIF concentrations in obese individuals. Subjects: Study participants were 71 men and women enrolled in The Cooper Institute Weight Management Program. Participants were predominantly female ( 68%, n = 48), middle- aged ( 46.5 ± 9.8 y), and severely obese ( BMI =43.0 ± 8.6). Method: Plasma MIF concentrations and other standard risk factors were measured before and after participation in a diet and physical activity based weight management program. Results: The mean follow- up was 8.5± 3.0 months with an average weight loss of 14.4 kg ( P< 0.001). The majority of clinical risk factors significantly improved at follow- up. Median levels of plasma MIF concentration were significantly lower at follow- up ( median [ IQR]; 5.1[ 3.6 - 10.3]) compared to baseline ( 8.4 [ 4.3 - 48.8]; P = 0.0005). The percentage of participants with plasma MIF concentration ≥ 19.5 mg/ nl ( highest tertile at baseline) decreased from 33.8 to 5.6% ( P< 0.001). Further, elevated baseline plasma MIF concentration was associated with markers of β- cell dysfunction and reductions in MIF were associated with improvements in β- cell function. Conclusions: Circulating MIF concentrations are elevated in obese but otherwise healthy individuals; however, this elevation in MIF is not uniform across individuals. In obese individuals with elevated circulating MIF concentrations, participation in physical activity and a dietary- focused weight management program resulted in substantial reduction in MIF.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 17 条
  • [1] The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle
    Benigni, F
    Atsumi, T
    Calandra, T
    Metz, C
    Echtenacher, B
    Peng, T
    Bucala, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (10) : 1291 - 1300
  • [2] Evidence for a role of macrophage migration inhibitory factor in vascular disease
    Chen, ZP
    Sakuma, M
    Zago, AC
    Zhang, XB
    Shi, C
    Leng, L
    Mizue, Y
    Bucala, R
    Simon, DI
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) : 709 - 714
  • [3] Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule
    Donn, RP
    Ray, DW
    [J]. JOURNAL OF ENDOCRINOLOGY, 2004, 182 (01) : 1 - 9
  • [4] Neuroendocrine properties of macrophage migration inhibitory factor (MIF)
    Fingerle-Rowson, GR
    Bucala, R
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2001, 79 (04) : 368 - 375
  • [5] Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease
    Isidori, AM
    Kaltsas, GA
    Korbonits, M
    Pyle, M
    Gueorguiev, M
    Meinhardt, A
    Metz, C
    Petrovsky, N
    Popovic, V
    Bucala, R
    Grossman, AB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) : 1834 - 1840
  • [6] Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease
    Lue, HQ
    Kleemann, R
    Calandra, T
    Roger, T
    Bernhagen, J
    [J]. MICROBES AND INFECTION, 2002, 4 (04) : 449 - 460
  • [7] Marlatt GA., 1980, Behavioral medicine: changing health lifestyles, P410
  • [8] Mechanisms and effectors of MIF-dependent promotion of tumourigenesis
    Mitchell, RA
    [J]. CELLULAR SIGNALLING, 2004, 16 (01) : 13 - 19
  • [9] *NIH NAT HEART LUN, 1998, CLIN GUID ID EV TREA, P1
  • [10] Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice
    Pan, JH
    Sukhova, GK
    Yang, JT
    Wang, B
    Xie, T
    Fu, HX
    Zhang, X
    Satoskar, AR
    David, JR
    Metz, CN
    Bucala, R
    Fang, K
    Simon, DI
    Chapman, HA
    Libby, P
    Shi, GP
    [J]. CIRCULATION, 2004, 109 (25) : 3149 - 3153